Advertisement
Screener

ImageneBio, Inc. (IMA) Expense Breakdown

ImageneBio, Inc. Expense Breakdown

No Expense Breakdown for IMA on this site yet.

  • 2026-06-30: Consulting and Professional Services $1.50M; Personnel Related $1.47M; Facilities Related and Other $1.38M; Stock-based compensation $769.00K.
  • 2025-06-30: Consulting and Professional Services $645.00K; Personnel Related $589.00K; Facilities Related and Other $471.00K; Stock-based compensation $0.00.

Source checked: the stored Expense Breakdown page for IMA.

Expenses by product

General and Administrative Expense: each quarter (3 month)

Quarter endConsulting and Professional ServicesPersonnel RelatedFacilities Related and OtherStock-based compensation
2026-06-30$1.50M$1.47M$1.38M$769.00K
2025-06-30$645.00K$589.00K$471.00K$0.00

Research and development: each quarter (3 month)

Quarter endPersonnel RelatedStock-based compensationDirect Program CostsOther Unallocated Expense
2026-06-30$1.04M$142.00K$5.37M$110.00K
2025-06-30$774.00K$0.00$4.88M$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B